Caroline A. Lee

5.4k total citations
27 papers, 1.4k citations indexed

About

Caroline A. Lee is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Caroline A. Lee has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pharmacology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Caroline A. Lee's work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Caroline A. Lee is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Caroline A. Lee collaborates with scholars based in United States, United Kingdom and Germany. Caroline A. Lee's co-authors include Kent L. Kunze, Sidney D. Nelson, John T. Slattery, Kenneth E. Thummel, Ping Zhao, Jack Cook, Eric L. Reyner, Ying Jiang, Rheem A. Totah and Dennis A. Smith and has published in prestigious journals such as Nature Reviews Drug Discovery, Journal of Medicinal Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Caroline A. Lee

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline A. Lee United States	19	691	590	277	266	166	27	1.4k
Stephanie Faucette United States	14	984 1.4×	571 1.0×	322 1.2×	229 0.9×	192 1.2×	26	1.6k
Donald Tweedie United States	24	834 1.2×	568 1.0×	499 1.8×	230 0.9×	108 0.7×	49	1.6k
Annikka Kalliokoski Finland	9	423 0.6×	710 1.2×	203 0.7×	396 1.5×	139 0.8×	12	1.2k
Robert Elsby United Kingdom	20	551 0.8×	729 1.2×	367 1.3×	363 1.4×	140 0.8×	25	1.6k
A. David Rodrigues United States	26	924 1.3×	772 1.3×	416 1.5×	328 1.2×	106 0.6×	49	1.8k
Kathryn E. Kenworthy United Kingdom	15	771 1.1×	1.0k 1.8×	302 1.1×	557 2.1×	129 0.8×	16	1.6k
Mitchell E. Taub United States	19	390 0.6×	908 1.5×	354 1.3×	464 1.7×	139 0.8×	51	1.4k
Tian J. Yang United States	15	721 1.0×	365 0.6×	314 1.1×	85 0.3×	157 0.9×	28	1.2k
Hidetaka Kamimura Japan	24	651 0.9×	676 1.1×	423 1.5×	255 1.0×	59 0.4×	98	1.6k
Imad Hanna United States	20	660 1.0×	520 0.9×	283 1.0×	187 0.7×	73 0.4×	30	1.1k

Countries citing papers authored by Caroline A. Lee

Since Specialization

Citations

This map shows the geographic impact of Caroline A. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline A. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline A. Lee more than expected).

Fields of papers citing papers by Caroline A. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline A. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline A. Lee. The network helps show where Caroline A. Lee may publish in the future.

Co-authorship network of co-authors of Caroline A. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline A. Lee. A scholar is included among the top collaborators of Caroline A. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline A. Lee. Caroline A. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Caroline A., Stefan Schreiber, Brian Bressler, et al.. (2024). Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults. Clinical Pharmacology in Drug Development. 13(5). 534–548. 8 indexed citations

Lee, Caroline A., Yong Tang, Ping Yi, et al.. (2023). Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism. Clinical Pharmacology in Drug Development. 12(6). 553–571. 9 indexed citations

Vildhede, Anna, Tommy B. Andersson, Fredrik Erlandsson, et al.. (2021). In Vitro Assessment of the Drug–Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters. Journal of Pharmacology and Experimental Therapeutics. 378(2). 108–123. 3 indexed citations

Zamek‐Gliszczynski, Maciej J., Mitesh Patel, Xinning Yang, et al.. (2020). Intestinal P‐gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications. Clinical Pharmacology & Therapeutics. 109(1). 55–64. 39 indexed citations

Zamek‐Gliszczynski, Maciej J., Xiaoyan Chu, Jack Cook, et al.. (2018). ITC Commentary on Metformin Clinical Drug–Drug Interaction Study Design That Enables an Efficacy‐ and Safety‐Based Dose Adjustment Decision. Clinical Pharmacology & Therapeutics. 104(5). 781–784. 30 indexed citations

Billington, Sarah, Adrian S. Ray, Laurent Salphati, et al.. (2017). Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS Proteomics. Drug Metabolism and Disposition. 46(2). 189–196. 51 indexed citations

Lee, Caroline A., Tasha K. Ritchie, Aleksandra Galetin, et al.. (2015). Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design. Drug Metabolism and Disposition. 43(4). 490–509. 108 indexed citations

Lee, Caroline A., Rüdiger Kaspera, Ying Jiang, et al.. (2012). Identifying a Selective Substrate and Inhibitor Pair for the Evaluation of CYP2J2 Activity. Drug Metabolism and Disposition. 40(5). 943–951. 78 indexed citations

Taub, Mitchell E., Rucha Sane, Harma Ellens, et al.. (2011). Digoxin Is Not a Substrate for Organic Anion-Transporting Polypeptide Transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but Is a Substrate for a Sodium-Dependent Transporter Expressed in HEK293 Cells. Drug Metabolism and Disposition. 39(11). 2093–2102. 57 indexed citations

10.

Lee, Caroline A., Jack Cook, Eric L. Reyner, & Dennis A. Smith. (2010). P-glycoprotein related drug interactions: clinical importance and a consideration of disease states. Expert Opinion on Drug Metabolism & Toxicology. 6(5). 603–619. 58 indexed citations

11.

Lee, Caroline A., Kathleen M. Hillgren, Lei Zhang, & Joseph W. Polli. (2010). Response from the International Transporter Consortium. Nature Reviews Drug Discovery. 10(1). 75–75. 1 indexed citations

12.

Lee, Caroline A., Deepak Dalvie, Michael R. Wester, et al.. (2009). Identification of Novel Substrates for Human Cytochrome P450 2J2. Drug Metabolism and Disposition. 38(2). 347–356. 110 indexed citations

13.

Zhao, Ping, Caroline A. Lee, & Kent L. Kunze. (2007). Sequential Metabolism Is Responsible for Diltiazem-Induced Time-Dependent Loss of CYP3A. Drug Metabolism and Disposition. 35(5). 704–712. 30 indexed citations

14.

Zhao, Ping, Kent L. Kunze, & Caroline A. Lee. (2005). EVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTES. Drug Metabolism and Disposition. 33(6). 853–861. 63 indexed citations

15.

Webber, Stephen E., Joseph Marakovits, Peter S. Dragovich, et al.. (2001). Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(20). 2683–2686. 10 indexed citations

16.

Lee, Caroline A., et al.. (1997). Mechanism of cytochrome P450 activation by caffeine and 7,8-benzoflavone in rat liver microsomes.. PubMed. 25(10). 1150–6. 19 indexed citations

17.

Lee, Caroline A., et al.. (1996). Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 287–291. 20 indexed citations

18.

Lee, Caroline A., Thomas A. Kost, & Cosette J. Serabjit‐Singh. (1996). [9] Recombinant baculovirus strategy for coexpression of functional human cytochrome P450 and P450 reductase. Methods in enzymology on CD-ROM/Methods in enzymology. 272. 86–95. 10 indexed citations

19.

Thummel, Kenneth E., Caroline A. Lee, Kent L. Kunze, Sidney D. Nelson, & John T. Slattery. (1993). Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by Human CYP3A4. Biochemical Pharmacology. 45(8). 1563–1569. 245 indexed citations

20.

Thummel, Kenneth E., John T. Slattery, Sidney D. Nelson, Caroline A. Lee, & Paul G. Pearson. (1989). Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes. Toxicology and Applied Pharmacology. 100(3). 391–397. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact